APP+, a fluorescent analogue of the neurotoxin MPP+, is a marker of catecholamine neurons in brain tissue, but not a fluorescent false neurotransmitter

ACS Chemical Neuroscience

Volumn 4, Issue 5, 2013, Pages 858-869

  Karpowicz, Richard J ^a   Dunn, Matthew ^a   Sulzer, David ^b,c   Sames, Dalibor ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

acute mouse brain slice; APP+; catecholamine neurons; fluorescent false neurotransmitters; neuronal imaging agent; two photon microscopy

Indexed keywords

4 (DIMETHYLAMINO)PHENYL 1 METHYLPYRIDINIUM; DOPAMINE TRANSPORTER; FLUORESCENT DYE; NORADRENALIN TRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE NERVE CELL; CONTROLLED STUDY; DEPOLARIZATION; INNERVATION; MALE; MESENCEPHALON; MOUSE; NERVE ENDING; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL;

1-METHYL-4-PHENYLPYRIDINIUM; ADRENERGIC NEURONS; ANILINE COMPOUNDS; ANIMALS; AXONS; BRAIN; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINERGIC NEURONS; FLUORESCENT DYES; MICE; MITOCHONDRIA; NEOSTRIATUM; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PRESYNAPTIC TERMINALS; PYRIDINIUM COMPOUNDS; SYNAPSES; SYNAPTIC VESICLES;

EID: 84877798003     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn400038u     Document Type: Article

References (55)

1. Banks, R. W. (1999) Cytological staining methods. In Modern Techniques in Neuroscience Research (Windhorst, U. and Johansson, H., Eds.), pp 1-26, Springer-Verlag, Berlin & Heidelberg.
2. Nimmerjahn, A., Kirchhoff, F., Kerr, J. N., and Helmchen, F. (2004) Sulforhodamine 101 as a specific marker of astroglia in the neocortex in vivo Nat. Methods 1, 31-37
3. Lee, J.-S., Kim, Y. K., Vendrell, M., and Chang, Y.-T. (2009) Diversity-oriented fluorescence library approach for the discovery of sensors and probes Mol. BioSyst. 5, 411-421
4. Haugland, R. P. (2002) Handbook of Fluorescent Probes and Research Products (Gregory, J., Ed.), 9 th ed., Molecular Probes, Inc., Eugene, OR.
5. 2+ Oscillations Induced by Hormonal Stimulation of Individual Fura-2-loaded Hepatocytes J. Biol. Chem. 264, 12859-12866
6. Tsien, R. Y. (1980) New calcium indicators and buffers with high selectivity against magnesium and protons: Design, synthesis, and properties of prototype structures Biochemistry 19, 2396-2404
7. Peterka, D., Takahashi, H., and Yuste, R. (2011) Imaging Voltage in Neurons Neuron 69, 9-21
8. Gaffield, M. A. and Betz, W. J. (2006) Imaging synaptic vesicle exocytosis and endocytosis with FM dyes Nat. Protoc. 1, 2916-2921
9. Sames, D., Dunn, M., Krapowicz, R. J., Jr., and Sulzer, D. (2013) Visualizing Neurotransmitter Secretion at Individual Synapses. ACS Chem. Neurosci. DOI: 10.1021/cn4000956.
10. Gubernator, N. G., Zhang, H., Staal, R. G. W., Mosharov, E. V., Pereira, D. B., Yue, M., Balsanek, V., Vadola, P. A., Mukherjee, B., Edwards, R. H., Sulzer, D., and Sames, D. (2009) Fluorescent False Neurotransmitters Visualize Dopamine Release from Individual Presynaptic Terminals Science 324, 1441-1444
11. Rodriguez, P. C., Pereira, D. B., Borgkvist, A., Wong, M. Y., Barnard, C., Sonders, M. S., Zhang, H., Sames, D., and Sulzer, D. (2013) Fluorescent dopamine tracer resolves individual dopaminergic synapses and their activity in the brain Proc. Natl. Acad. Sci. U.S.A. 110, 870-875
12. Wise, R. A. (2004) Dopamine, learning and motivation Nat. Rev. Neurosci. 5, 483-494
13. Arbuthnott, G. W. and Wickens, J. (2007) Space, time and dopamine Trends Neurosci. 30, 62-69
14. Sotnikova, T. D., Beaulieu, J.-M., Gainetdinov, R. R., and Caron, M. G. (2006) Molecular biology, pharmacology and functional role of the plasma membrane dopamine transporter CNS Neurol. Disord.: Drug Targets 5, 45-56
15. Javitch, J. A., D'Amato, R. J., Strittmatter, S. M., and Snyder, S. H. (1985) Parkinsonism-inducing neurotoxin, N -methyl-4-phenyl-1,2,3,6- tetrahydropyridine: Uptake of metabolite N- methyl-4-phenylpyridine by dopamine neurons explains selective toxicity Proc. Natl. Acad. Sci. U.S.A. 82, 2173-2177
16. Gainetdinov, R. R., Fumagalli, F., Jones, S. R., and Caron, M. G. (1997) Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter J. Neurochem. 69, 1322-1325
17. Buck, K. J. and Amara, S. G. (1994) Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium Proc. Natl. Acad. Sci. U.S.A. 91, 12584-12588
18. Wall, S. C., Gu, H., and Rudnick, G. (1995) Biogenic Amine Flux Mediated by Cloned Transporters Stably Expressed in Cultured Cell Lines: Amphetamine Specificity for Inhibition and Efflux Mol. Pharmacol. 47, 544-550
19. Yelin, R. and Schuldiner, S. (1995) The pharmacological profile of the vesicular monoamine transporter resembles that of multidrug transporters FEBS Lett. 337, 201-207
20. Staal, R. G. and Sonsalla, P. K. (2000) Inhibition of Brain Vesicular Monoamine Transporter (VMAT2) Enhances 1-Methyl-4-phenylpyridinium Neurotoxicity In Vivo in Rat Striata J. Pharmacol. Exp. Ther. 293, 336-342
21. Liu, Y., Peter, D., Roghani, A., Schuldiner, S., Privé, G. G., Eisenberg, D., Brecha, N., and Edwards, R. H. (1992) A cDNA That Suppresses MPP+ Toxicity Encodes a Vesicular Amine Transporter Cell 70, 539-551
22. Singer, T. P., Ramsay, R. R., McKeown, K., Trevor, A., and Castagnoli, N. E. (1988) Mechanism of the Neurotoxicity of 1-Methyl-4-phenylpyridinium (MPP+), the Toxic Bioactivation Product of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Toxicology 49, 17-23
23. Keller, H. H. and da Prada, M. (1985) Evidence for the release of 1-methyl-4-phenylpyridinium (MPP+) from rat striatal neurons in vitro Eur. J. Pharmacol. 119, 247-250
24. Schwartz, J. W., Blakely, R. D., and DeFelice, L. J. (2003) Binding and Transport in Norepinephrine Transporters J. Biol. Chem. 278, 9768-9777
25. Schwartz, J. W., Novarino, G., Piston, D. W., and DeFelice, L. J. (2005) Substrate Binding Stoichiometry and Kinetics of the Norepinephrine Transporter J. Biol. Chem. 280, 19177-19184
26. Brown, A. S., Bernal, L.-M., Micotto, T. L., Smith, E. L., and Wilson, J. N. (2011) Fluorescent neuroactive probes based on stilbazolium dyes Org. Biomol. Chem. 9, 2142-2148
27. Kolomoitsev, P. R. (1962) Antibacterial properties of some N-substituted pyridine derivatives Mikrobiol. Z. 24, 23-27
28. Hutchings, M. G. (1984) Structure-colour relationships of some new N -arylpyridinium hemicyanine dyes Tetrahedron 40, 2061-2068
29. Fromherz, P. and Heilemann, A. (1992) Twisted Internal Charge Transfer in (Aminophenyl)pyridinium J. Phys. Chem. 96, 6864-6866
30. Bereiter-Hahn, J. (1976) Dimethylaminostyrylmethylpyridiniumiodine (daspmi) as a fluorescent probe for mitochondria in situ Biochim. Biophys. Acta 423, 1-14
31. Betz, W. J., Mao, F., and Bewick, G. S. (1992) Activity-dependent fluorescent staining and destaining of living vertebrate motor nerve terminals J. Neurosci. 12, 363-375
32. Blakely, R. D., Mason, J. N., Tomlinson, I. D., and Rosenthal, S. J. Fluorescent Substrates for Neurotransmitter Transporters. U.S. Patent 7,947,255, May 24, 2011.
33. +) is a Fluorescent Substrate for the Human Serotonin Transporter J. Biol. Chem. 287, 8852-8863
34. Parker, L. K., Shanks, J. A., Kennard, J. A., and Brain, K. L. (2010) Dynamic monitoring of NET activity in mature murine sympathetic terminals using a fluorescent substrate Br. J. Pharmacol. 159, 797-807
35. Jørgensen, S., Nielson, E. Ø., Peters, D., and Dyhring, T. (2008) Validation of a fluorescence-based high-throughput assay for the measurement of neurotransmitter transporter uptake activity J. Neurosci. Methods 169, 168-176
36. Bernstein, A. I., Stout, K. A., and Miller, G. W. (2012) A fluorescent-based assay for live cell, spatially resolved assessment of vesicular monoamine transporter 2-mediated neurotransmitter transport J. Neurosci. Methods 209, 357-366
37. Chang, J. C., Tomlinson, I. D., Warnement, M. R., Ustione, A., Carneiro, A. M., Piston, D. W., Blakely, R. D., and Rosenthal, S. J. (2012) Single Molecule Analysis of Serotonin Transporter Regulation Using Antagonist- Conjugated Quantum Dots Reveals Restricted, p38 MAPK-Dependent Mobilization Underlying Uptake Activation J. Neurosci. 32, 8919-8929
38. Biekmann, B. S., Tomlinson, I. D., Rosenthal, S. J., and Andrews, A. M. (2012) Serotonin Uptake is Largely Mediated by Platelets versus Lymphocytes in Peripheral Blood Cells ACS Chem. Neurosci. 4, 161-170
39. Matsushita, N., Okada, H., Yasoshima, Y., Takahashi, K., Kazutoshi, K., and Kobayashi, K. (2002) Dynamics of tyrosine hydroxylase promoter activity during midbrain dopaminergic neuron development J. Neurochem. 82, 295-304
40. Borgden, R. N., Heel, R. C., Speight, T. M., and Avery, G. S. (1979) Nomifensine: A review of its pharmacological properties and therapeutic efficacy in depressive illness Drugs 18, 1-24
41. Sanders, J. D., Happe, H. K., Bylund, D. B., and Murrin, L. C. (2005) Development of the Norepinephrine Transporter in the Rat CNS Neuroscience 130, 107-117
42. Murrin, L. C., Sanders, J. D., and Bylund, D. B. (2007) Comparison of the maturation of the adrenergic and serotonergic neurotransmitter systems in the brain: Implications for differential drug effects on juveniles and adults Biochem. Pharmacol. 73, 1225-1236
43. Bamford, N. S., Zhang, H., Schmitz, Y., Wu, N. P., Cepeda, C., Levine, M. S., Schmauss, C., Zakharenko, S. S., Zablow, L., and Sulzer, D. (2004) Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals Neuron 42, 653-663
44. Wong, M. Y., Sulzer, D., and Bamford, N. S. (2011) Imaging presynaptic exocytosis in corticostriatal slices Methods Mol. Biol. 793, 363-376
45. Davis, G. C., Williams, A. C., Markey, S. P., Ebert, M. H., Caine, E. D., Reichert, C. M., and Kopin, I. J. (1979) Chronic Parkinsonism Secondary to Intravenous Injection of Meperidine Analogues Psychiatry Res. 1, 249-254
46. Nirenberg, M. J., Chan, J., Liu, Y., Edwards, R. H., and Pickel, V. M. (1996) Ultrastructural Localization of the Vesicular MonoamineTransporter-2 in Midbrain Dopaminergic Neurons: Potential Sites for Somatodendritic Storage and Release of Dopamine J. Neurosci. 16, 4135-4145
47. Nirenberg, M. J., Chan, J., Liu, Y., Edwards, R. H., and Pickel, V. M. (1997) Vesicular monoamine transporter-2: immunogold localization in striatal axons and terminals Synapse 26, 194-198
48. Adam, Y., Edwards, R. H., and Schuldiner, S. (2008) Expression and function of the rat vesicular monoamine transporter 2 Am. J. Physiol.: Cell Physiol. 294, C1004-C1011
49. Li, D., Hérault, K., Oheim, M., and Ropert, N. (2009) FM dyes enter via a store-operated calcium channel and modify calcium signaling of cultured astrocytes Proc. Natl. Acad. Sci. U.S.A. 106, 21960-21965
50. 2) and Evidence for the Expression of the Transporter in the Brain J. Biol. Chem. 273, 32776-32786
51. Duan, H. and Wang, J. (2010) Selective Transport of Monoamine Neurotransmitters by Human Plasma Membrane Monoamine Transporter and Organic Cation Transporter 3 J Pharmacol. Exp. Ther. 335, 743-753
52. Kucheryavykh, L. Y., Kucheryavykh, Y. V., Rolón-Reyes, K., Skatchkov, S. N., Eaton, M. J., Cubano, L. A., and Inyushin, M. (2012) Visualization of implanted GL261 glioma cells in living mouse brain slices using fluorescent 4-(4-(dimethylamino)-styryl)- N -methylpyridinium iodide (ASP+) Biotechniques 53, 305-309
53. Starke, K. (1983) Amezinium: A novel pattern of effects on the sympathetic nervous system Trends. Pharmacol. Sci. 4, 269-272
54. Ramadass, R. and Bereiter-Hahn, J. (2008) How DASPMI reveals mitochondrial membrane potential: fluorescence decay kinetics and steady-state anisotropy in living cells Biophys. J. 95, 4068-4076
55. Manders, E. M. M., Verbeek, F. J., and Aten, J. A. (1993) Measurement of co-localization of objects in dual-colour confocal images J. Microsc. 169, 375-382